AmberNoon
Dermatologist designed sun protective apparel, accessories, and skin care for men, women and children. Our textiles do not use UV chemical finishes and sustain UV protection through 40 washes.
A woman of diverse interests, Dr. Ilyas founded a clothing line called AmberNoon. She created this contemporary line as a way of providing sun protection for people who are not adequately protecting themselves from the sun’s harmful UV rays.
This clothing line is an extension of her experience as a dermatologist. With the incidence of skin cancer still rising, it is her hope that more people will recognize and understand the need for daily sun protection. She started with women’s clothing and rapidly grew to include accessories and swimwear. She is introducing men’s and children’s clothing during the summer of 2019. The company started online in late 2017 and rapidly grew to start a flagship store in Wayne, Pennsylvania and is also featured at the Market @ Macy’s in Fort Lauderdale and Atlanta.
In 2020, she launched a diffusion line called AmberNoon II by Dr Erum Ilyas made exclusively for QVC.
Her goal is to impact more lives with this positive message, and to do her part to increase awareness and reduce the incidence of skin cancer.
This clothing line is an extension of her experience as a dermatologist. With the incidence of skin cancer still rising, it is her hope that more people will recognize and understand the need for daily sun protection. She started with women’s clothing and rapidly grew to include accessories and swimwear. She is introducing men’s and children’s clothing during the summer of 2019. The company started online in late 2017 and rapidly grew to start a flagship store in Wayne, Pennsylvania and is also featured at the Market @ Macy’s in Fort Lauderdale and Atlanta.
In 2020, she launched a diffusion line called AmberNoon II by Dr Erum Ilyas made exclusively for QVC.
Her goal is to impact more lives with this positive message, and to do her part to increase awareness and reduce the incidence of skin cancer.